International Journal of
Medicine and Medical Sciences

  • Abbreviation: Int. J. Med. Med. Sci.
  • Language: English
  • ISSN: 2006-9723
  • DOI: 10.5897/IJMMS
  • Start Year: 2009
  • Published Articles: 535

Full Length Research Paper

Histopathological study of prostatic lesions on needle biopsies with serum prostate-specific antigen (PSA)

Rukhsana Akhter
  • Rukhsana Akhter
  • Department of Pathology, Government Medical College, 190006, Srinagar, India.
  • Google Scholar
Ruby Reshi
  • Ruby Reshi
  • Department of Pathology, Government Medical College, 190006, Srinagar, India.
  • Google Scholar
Zubair Ahmad Dar*
  • Zubair Ahmad Dar*
  • Departmen of Zoology, University Of Kashmir, Srinigar-190006
  • Google Scholar
Parvaiz Ahmad Dar
  • Parvaiz Ahmad Dar
  • Departmen of Zoology, University Of Kashmir, Srinigar-190006
  • Google Scholar


  •  Accepted: 24 February 2014
  •  Published: 31 March 2014

References

Amayo A, Obara W (2004). Serum Prostate Specific Antigen Levels in Men with Benign Prostatic Hyperplasia and Cancer of Prostate. East Afr. Med. J. 81:1.
Crossref 
 
Lodding P, Aus G, Bergdah S, Frösing R, Lilja H, Pihl CG, Hugosson J (1998). Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen. J. Urol. 159(3):899-903.
Crossref 
 
Berman JJ, Moore GW, Alonsozana ELC, Mamo GF (1994). Elevated prostate specific antigen level and the negative prostate biopsy. South Med. J. 87(2):290-291.
Crossref
 
Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A (1998). Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279:1542–7.
Crossref
 
Chawla R, Rebecca Abraham, U Arora, Kim Mammen (2003) Effect of Urinary retention on the levels of prostate specific antigen (PSA) and prostate acid phosphatase (PAP) in prostate disease. Indian J. Urol. 19:120-4
 
Di Sant'Agnese PA (1992). Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol. 23:287-296.
Crossref
 
Bostwick DG, Qian J, Hossain D (2008). Non-neoplastic diseases of the prostate. In: Bostwick DG, Qian J, Hossain D (eds.), Urologic Surgical Pathology. 1st Edition, St Louis, USA.
Crossref
 
Farnswork WE (1973). Human prostatic reverse transcriptase and RNA-virus. Urol. Res. 1:106.
 
Ferro MA, Barnes I, Roberts JB, Smith PJ (1987) Tumor markers in prostatic carcinoma: A comparison of prostate-specific antigen with acid phosphatase. Br. J. Urol. 60:69-73.
Crossref
 
Foster CS, Deshmukh M (1992). Grading prostate cancer. In: Foster CS, Botwick DG (eds.), Pathology of Carcinoma of Prostate. Philadelphia: WB Saunders. 70(Suppl 0):233-234.
 
Gupta NP, Ansari MS, Dass SC (2005). Transrectal Ultrasound Guided Biopsy (TRUS) guided prostate biopsy. Indian J. Cancer 42(3):151-154.
Crossref 
 
 
Iczkowski KA, Basselor TJ, Schwob VS (1998). The diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. Urology 51:749-757.
Crossref
 
McNeal JE (1978). Origin and evaluation of benign prostatic enlargement. Invest. Urol.15:340-345.
Pubmed
 
Okada K, Kojima M, Naya Y, Kamoi K (2000). Correlation of histological inflammation in needle biopsy specimens with serum prostate specific antigen levels in men with negative biopsy for prostate cancer. Urology 55(6):892-898.
Crossref
 
Warhol MJ, Longtine JA (1985). The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates. J. Urol. 134:607-613.
Pubmed